Home Applications 212496 Application 212496
Type ANDA
Sponsor WILSHIRE PHARMS INC Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A212496-001 DOFETILIDE DOFETILIDE 0.125MG CAPSULE / ORAL AB 2026-07-29 A212496-002 DOFETILIDE DOFETILIDE 0.25MG CAPSULE / ORAL AB 2026-07-29 A212496-003 DOFETILIDE DOFETILIDE 0.5MG CAPSULE / ORAL AB 2026-07-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A212496-001 DOFETILIDE 0.125MG CAPSULE / ORAL AB 2026-07-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 A212496-002 DOFETILIDE 0.25MG CAPSULE / ORAL AB 2026-07-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 A212496-003 DOFETILIDE 0.5MG CAPSULE / ORAL AB 2026-07-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 A212496-001 DOFETILIDE 0.125MG CAPSULE / ORAL AB 2026-07-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A212496-002 DOFETILIDE 0.25MG CAPSULE / ORAL AB 2026-07-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A212496-003 DOFETILIDE 0.5MG CAPSULE / ORAL AB 2026-07-29 caaa826d4ba7…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.